AimDeregulation of FOXM1 has been documented in various cancers. The aim of this study was to evaluate the role of FOXM1 in ovarian cancer tumorigenesis and paclitaxel resistance. Experimental designExpression of FOXM1 was examined in 119 clinical samples by immunohistochemistry and correlated with clinicopathological parameters. https://mellerbrands.shop/product-category/chains/